ASCO Daily News
ASCO Daily News is the official conference reporter of the American Society of Clinical Oncology (ASCO), providing high-quality, unbiased research summaries and oncology news to ASCO members and oncology health care providers.
ASCO Daily News is the official conference reporter of the American Society of Clinical Oncology (ASCO), providing high-quality, unbiased research summaries and oncology news to ASCO members and oncology health care providers.
PURPOSE Datopotamab deruxtecan (Dato-DXd) is an antibody-drug conjugate consisting of a humanized antitrophoblast cell-surface antigen 2 (TROP2) monoclonal antibody linked to a potent, exatecan-derived topoisomerase…
Objective To describe the clinicopathological characteristics and survival outcomes of ovarian neuroendocrine neoplasms from a curated registry. Methods This is a retrospective cross-sectional study of…
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…
EGFR is often found to be constitutively activated in human cancer. Dobersberger et al. develop an engineering strategy for the generation of binding domains specifically recognizing…
DAY 1 (GU Oncology)February 5, 2024 Start 6pm CET 12 noon EST6pm-6:20 (CET)12 noon-12:20 (EST)Gilberto Morgan (20 min) FDA Approvals in Oncology, OncoAlert …
The OncoAlert Newsletter is now out for June 23-29, 2023
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…
Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to